During the COVID-19 pandemic, GISAID has been the largest repository for sequenced SARS-CoV-2 genomes.
GISAID received several million dollars in additional funding for its operations during the pandemic from such sources as the World Health Organization, China, Pfizer, Janssen, and Merck.1)